Teladoc Health announced on August 27, 2026 that it has hired Michael Grasher as its new Chief Financial Officer, effective August 31. Charles Divita III, who had been serving as interim principal financial officer, will continue as CEO. Grasher, 61, previously served as CFO at IFG Companies, Fortegra Group, and AMERISAFE — all insurance-sector companies — and also worked as an equity research analyst covering insurers. His compensation package includes a $550,000 annual base salary, a $500,000 one-time sign-on bonus, an annual bonus targeted at 85% of base salary, and approximately $3 million in equity awards split evenly between restricted stock units and performance stock units tied to 2026 adjusted EBITDA and 2026–2028 revenue compound annual growth rate.
View Full Filing (SEC EDGAR)